GRFS Grifols
- 9.490
- -0.010-0.11%
- 9.490
- 0.0000.00%
Grifols News
Grifols Holder Mason Capital Opposes Potential Transaction, Tells Board
Express News | Mason Capital Criticizes Grifols Board For Governance Failures And Shareholder Value Loss; Calls For Independent Directors And Improved Oversight; Claims Brookfield Transaction Undervalues Grifols
Mason Capital Management Highlights Corporate Governance Failures and Significant Shareholder Value Destruction Under Grifols Board of Directors
European Equities Traded in the US as American Depositary Receipts Fall in Friday Trading
Grifols Shares Rise After 3Q Sales Beat Views
6-K: Report of foreign private issuer (related to financial reporting)
Grifols Reports Q3 Adjusted EBITDA of EUR 462M, up 26.7% in Constant Currency
Grifols Reaffirms FY24 Guidance
Brookfield Awaiting Information for Potential Grifols Bid, Bloomberg Says
Express News | Brookfield Is Said To Seek Info On Grifols Related-Party Deals; Said To Be Confident It Can Line Up Financing
Earnings Preview: Grifols to Report Financial Results on November 07
Grifols And 2 Other Stocks That Might Be Trading Below Estimated Value
Grifols Receives FDA Approval To Treat Surgical Bleeding In Pediatric Patients With Its Fibrin Sealant Solution
Top Gap Ups and Downs on Monday: DJT, CUK, PHG and More
Grifols Falls on Report Brookfield Delays Offer on Funding Issues
Grifols to Test Eye Drops for Sulfur Mustard-Induced Ocular Injury
Grifols Partners With BARDA for PoC Testing of Ocular Immunoglobulin
Express News | Grifols Partners With BARDA For Testing Ocular Immunoglobulin Eye Drops As Treatment For Sulfur Mustard-Induced Eye Injury
Grifols Subsidiary GigaGen Awarded U.S. BARDA Contract
European Equities Traded in the US as American Depositary Receipts Decline in Thursday Trading
Analysis
Price Target
No Data
No Data